Headlines

Breaking Down Gilead Sciences: 22 Analysts Share Their Views

Latest Ratings for GILD

Date Firm Action From To
Mar 2022 Barclays Maintains Underweight
Mar 2022 RBC Capital Maintains Outperform
Feb 2022 BMO Capital Downgrades Outperform Market Perform

View More Analyst Ratings for GILD

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *